Könyv Comparative Analysis and Benchmarking Hung-Hsin Chen

Comparative Analysis and Benchmarking

Corporate Strategy Analysis of Four International Pharmaceutical Companies

Szerző: Hung-Hsin Chen
Nyelv: Angol
Kötés: Puha kötésű
Elérhetőség: Beszállítói készleten
Küldés 9-15 napon belül
11 033 Ft
This research of corporate strategy analysis implements comparative analysis and benchmarking to ana...

Információk a könyvről

Szerző
Nyelv
Angol
Kötés
Könyv - Puha kötésű
Kiadva
2003
oldal
140
EAN
9781581121896
ISBN
9781581121896
Enbook ID
08744013
Súly
266
Méretek
190 x 242 x 8

Teljes leírás

This research of corporate strategy analysis implements comparative analysis and benchmarking to analyse and examine the corporate strategy of the pharmaceutical sectors of 4 international pharmaceutical companies. This research adopts the hybrid approach of combining qualitative and quantitative methods in a two stages research design. Quantitative method is applied first to deal with the comparative figures, and then qualitative method is used to find out the problem. The design of this multiple research includes three phases: data collection, analysis, and reporting. The findings of this research can be divided into 4 parts: R&D/marketing, technology alliances, strategic acquisitions and merger, and manufacturing. The drug innovative projects are recommended being developed within the company's familiar therapeutic areas in order to take its marketing advantage. Through this comparative analysis, some of this type of problems of these international pharmaceutical companies is identified. A big pharmaceutical company forming alliances with some small biotechnology companies has become a trend within pharmaceutical industry since 1980s. For pharmaceutical companies, to take advantage of R&D through biotechnology is the main purpose of alliances with small biotechnology companies. It is important to note that most pharmaceutical acquisitions belong to the type of absorption with high resource transferring and low autonomy. Due to the high profit margin and the essential importance of R&D and marketing, the operation management of manufacturing of pharmaceutical industry is relatively poor. The low asset utilisation rate pointed out this problem. Academic researches have revealed that existing theories of operation management of manufacturing, such as action research, set-up reduction, teamwork, continuous improvement, collaboration, and involvement, are applicable and beneficial to pharmaceutical industry rather than waiting for the technology breakthroughs.

Érdekelheti

Cocoa

Leissle
24 680 Ft
19 991 Ft

GC

Gemma Collins
8 689 Ft

Decameron Tarot

Luciano Spadanuda
6 909 Ft
12 028 Ft

Blessed

Kate Bowler
18 197 Ft

Azok a vásárlók, akik ezt a könyvet megvásárolták, a következőket is megvásárolták

Leyes de educacion

Andrés Santana Muñoz
18 126 Ft
3 241 Ft

Tests de Grammaire Russe

Davidov Lev Davidov
3 196 Ft

Pageboy

Elliot Page
9 769 Ft

A nyaklánc

Matt Witten
5 546 Ft